BIO-TECHNE Corp (TECH) KPIs and segments
Close on Nov 12, 2026Market cap $11.44BP/E 66.8Yield 0.44%
KPIs & segments
Operating metrics and segments that drive Bio-Techne's business
Bio-Techne's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Bio-Techne's fiscal year ends June 30 — Q4 FY26 = CQ2 2026 (calendar quarter).
| Add to chart | Metric | Q4 FY26 CQ2 2026 | Q3 FY26 CQ1 2026 | Q2 FY26 CQ4 2025 | Q1 FY26 CQ3 2025 | Q4 FY25 CQ2 2025 | Q3 FY25 CQ1 2025 | Q2 FY25 CQ4 2024 | Q1 FY25 CQ3 2024 | Q4 FY24 CQ2 2024 | Q3 FY24 CQ1 2024 | Q2 FY24 CQ4 2023 | Q1 FY24 CQ3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein Sciences($M) | 231 | 226 | 215 | 202 | 226 | 228 | 212 | 205 | 214 | 215 | 198 | 205 | |
Diagnostics and Spatial Biology($M) | 90.1 | 85.6 | 81.2 | 79.5 | 89.7 | 89.2 | 84.1 | 83.2 | 90.7 | 87.5 | 75.4 | 72.8 | |
Earlier reporting (last reported 2025)2 | |||||||||||||
Product and Services($M) | 315 | 306 | 287 | 281 | 311 | 311 | 289 | 284 | 301 | 299 | 265 | 271 | |
Consumables($M) | 261 | 257 | 235 | 232 | 253 | 258 | 231 | 231 | 246 | 247 | 211 | 225 | |
Instruments($M) | 31.5 | 27.7 | 29.6 | 21.8 | 28.9 | 26.1 | 30.9 | 26.2 | 27.1 | 26.5 | 29.8 | 24.9 | |
Services($M) | 23.1 | 21.4 | 22.3 | 27.5 | 29.6 | 27.2 | 27.4 | 27.4 | 28.2 | 25.5 | 24.1 | 21.5 | |
Royalty revenues($M) | 5.87 | 4.97 | 8.51 | 5.65 | 5.51 | 5.04 | 8.10 | 5.05 | 5.05 | 4.70 | 7.52 | 6.07 | |
United States($M) | 166 | 167 | 147 | 155 | 176 | 182 | 160 | 165 | 178 | 173 | 148 | 159 | |
EMEA, excluding United Kingdom($M) | 80.3 | 73.4 | 75.4 | 65.1 | 70.3 | 66.5 | 70.4 | 59.1 | 63.6 | 60.5 | 62.5 | 54.8 | |
China($M) | 26.9 | 26.0 | 26.4 | 24.8 | 26.9 | 24.5 | 24.8 | 24.3 | 23.9 | 25.6 | 24.5 | 25.5 | |
APAC, excluding Greater China($M) | 22.1 | 21.8 | 22.7 | 19.1 | 18.9 | 21.2 | 19.0 | 18.1 | 19.3 | 18.3 | 19.0 | 17.4 | |
United Kingdom($M) | 14.5 | 14.9 | 13.7 | 13.2 | 14.8 | 12.9 | 13.2 | 13.9 | 11.8 | 15.1 | 10.7 | 12.4 | |
Rest of World($M) | 11.3 | 7.77 | 11.1 | 9.05 | 9.65 | 9.18 | 9.73 | 8.99 | 10.1 | 10.6 | 8.09 | 7.75 | |
Protein Sciences($M) | 97.1 | 100.0 | 84.6 | 77.7 | 98.8 | 104 | 87.1 | 80.5 | 92.0 | 94.8 | 79.6 | 88.4 | |
Diagnostics and Spatial Biology($M) | 10.1 | 10.3 | 8.43 | 8.88 | 5.38 | 8.42 | 3.24 | 4.28 | 11.4 | 8.10 | 4.56 | 0.53 | |
Earlier reporting (last reported 2024)1 | |||||||||||||
Protein Sciences($M) | 174 | 172 | 158 | 152 | 172 | 174 | 160 | 152 | |||||
Diagnostics and Spatial Biology($M) | 48.4 | 46.9 | 44.7 | 45.7 | 50.2 | 52.0 | 48.5 | 47.6 | |||||
16 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-24.
See a number that looks wrong?